Skip to main content
. 2018 Jul 26;13(11):1765–1776. doi: 10.2215/CJN.03960318

Figure 5.

Figure 5.

Example of two patients with ADPKD with the same age and GFR, who have a substantial difference in their prognosis on the basis of their total kidney volume and predicted rate of decline of eGFR. Patient A is classified as Mayo Clinic class 1E and would benefit form a disease-modifying treatment. Patient B has better prognosis (class 1B) and would need monitoring.